Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPUS: Roflumilast in COPD
NCT00076089Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Dec 2003; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00076089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076089.